The Journal of Experimental Medicine
Randox
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 14 May 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamad, A. R. A.
Right arrow Articles by Schneck, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamad, A. R. A.
Right arrow Articles by Schneck, J. P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/5/1113/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 10, May 21, 2001 1113-1122

Original Article

Lack of Coreceptor Allows Survival of Chronically Stimulated Double-negative {alpha}/ß T Cells: Implications for Autoimmunity

Abdel Rahim A. Hamada, Ananth Srikrishnana, Paria Mirmonsefa, Chris P.M. Broerenc, Carl H. Juned, Drew Pardollb, and Jonathan P. Schnecka
a Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
b Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
c Department of Immunology, Institute of Infectious Diseases and Immunology, University of Utrecht, 3584 CL Utrecht, The Netherlands
d Stellar Chance Laboratories, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Correspondence to: Abdel Rahim A. Hamad, Dept. of Pathology, Johns Hopkins School of Medicine, 720 Rutland Ave., Ross 664G, Baltimore, MD 21211. Tel:410-614-0642 Fax:410-614-3548 E-mail:ahamad{at}jhmi.edu.

Lymphoproliferative diseases are characterized by massive accumulation of CD4-CD8-B220+ (double-negative [DN]) T cells in peripheral organs. Although evidence indicates these cells are derived from mature autoreactive {alpha}/ß T cells, the significance of coreceptor downregulation is not known. In this study, we examined the role CD4 coreceptor plays in the survival of repeatedly stimulated T cells. CD4+/+ and CD4-/- T cells from AND T cell receptor (TCR) transgenic mice exhibited similar phenotypes after antigenic stimulation, but the CD4-/- T cells survived in much larger numbers than the CD4+/+ cells upon primary and secondary major histocompatibility complex (MHC)/peptide stimulation. Enhanced survival of CD4-/- T cells was due to decreased apoptosis rather than enhanced proliferation. Similarly, circumvention of the CD4/MHC interaction by using a surrogate TCR ligand that does not engage CD4 led to significant enhancement of CD4+/+ cells than when stimulated with MHC/peptide. Finally, we generated DN B220+ T cells using an in vitro model system and showed they were more tolerant to chronic stimulation than CD4+/+ cells. Together, these results indicate that coreceptor engagement controls expansion of normal T cells. In the absence of coreceptor, T cells survive chronic stimulation and express B220 as seen in autoimmune lymphoproliferative diseases.

Key Words: CD4 coreceptor, double-negative T cell, lymphoproliferation, B220, apoptosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS